1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Introduction to Market Drivers and Restraints 4.3 Market Drivers 4.3.1 INTRODUCTION of Regulatory Standards on Packaging and Stringent Norms against Counterfeit Products 4.3.2 Impact of Nanotechnology due to Innovative and New-Gen Packaging Solutions 4.4 Market Restraints 4.4.1 Fluctuations in Raw Material Cost Due to Suppliers Bargaining Power 4.5 Value Chain Analysis 4.6 Industry Attractiveness - Porter's Five Force Analysis 4.6.1 Threat of New Entrants 4.6.2 Bargaining Power of Buyers/Consumers 4.6.3 Bargaining Power of Suppliers 4.6.4 Threat of Substitute Products 4.6.5 Intensity of Competitive Rivalry 5 MARKET SEGMENTATION 5.1 By Material 5.1.1 Plastics 5.1.2 Paper & Paperboard 5.1.3 Glass 5.1.4 Metal 5.1.5 Other Matetials 5.2 By Product 5.2.1 Primary Packaging 5.2.1.1 Bottles 5.2.1.2 Blister Packaging 5.2.1.3 Prefillable Syringes 5.2.1.4 Vials & Ampuls 5.2.1.5 Other Primary Packaging Products 5.2.2 Secondary Packaging 5.2.2.1 Closures 5.2.2.2 Containers 5.2.2.3 Labels 5.2.2.4 Packaging Accessories 5.3 Geography 5.3.1 North America 5.3.1.1 United States 5.3.1.2 Canada 5.3.2 Europe 5.3.2.1 Germany 5.3.2.2 United Kingdom 5.3.2.3 France 5.3.2.4 Italy 5.3.2.5 Spain 5.3.2.6 Rest of Europe 5.3.3 Asia-Pacific 5.3.3.1 China 5.3.3.2 Japan 5.3.3.3 India 5.3.3.4 South Korea 5.3.3.5 Rest of Asia-Pacific 5.3.4 Latin America 5.3.4.1 Brazil 5.3.4.2 Mexico 5.3.4.3 Rest of Latin America 5.3.5 Middle East & Africa 5.3.5.1 Turkey 5.3.5.2 South Africa 5.3.5.3 Rest of Middle East & Africa 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Amcor Limited 6.1.2 3M Company 6.1.3 Schott AG 6.1.4 WestRock Company 6.1.5 Berry Global, Inc. 6.1.6 McKesson Corporation 6.1.7 AptarGroup, Inc. 6.1.8 Klöckner Pentaplast Group 6.1.9 CCL Industries Inc. 6.1.10 FlexiTuff International Ltd. 6.1.11 Gerresheimer AG 6.1.12 West Pharmaceutical Services, Inc. 6.1.13 Becton, Dickinson and Company 6.1.14 Vetter Pharma International GmbH 7 INVESTMENT ANALYSIS 8 MARKET OPPORTUNITIES AND FUTURE TRENDS